Photo of Ryan J. Wichtowski

Ryan J. Wichtowski

Partner, Cravath

212-474-1507rwichtowski@cravath.com

Two Manhattan West
375 Ninth Avenue
New York, NY 10001

View Firm Biography

Ryan J. Wichtowski advises Cravath's clients on a broad range of complex intellectual property issues, including those that arise in the context of corporate and financing transactions. His transactional experience includes counseling clients on mergers and acquisitions, spin‑offs and separations, complex licensing arrangements, partnerships, joint ventures and collaborations.

Lawdragon Honors

Honor Year Practice
The 2026 Lawdragon 500 Leading Global Cyber Lawyers 2026 Transactions, inc. Digital Infrastructure

Wichtowski’s notable matters include representing:

  • Disney in its $85 billion acquisition of 21st Century Fox, the $3.47 billion sale of its interest in the YES Network to an investor group including the Yankees and Sinclair, the combination of its Hulu + Live TV business with Fubo and ESPN’s proposed joint venture with Fox and Warner Bros. Discovery to launch Venu Sports;
  • Thermo Fisher Scientific in its $20.9 billion acquisition of PPD;
  • Johnson & Johnson in its $16.6 billion acquisition of Abiomed and its $6.5 billion acquisition of Momenta;
  • Brookfield Renewable in its $2.8 billion acquisition of Duke Energy Renewables;
  • Valvoline in the $2.65 billion sale of its Global Products business to Aramco;
  • Vista Outdoor in the $2.225 billion sale of The Kinetic Group to Czechoslovak Group and the $1.125 billion sale of Revelyst to SVP;
  • Cowen in its $1.9 billion acquisition by TD;
  • Atalaya Capital Management in its $800 million sale to Blue Owl Capital;
  • altafiber in the $670 million sale of CBTS to TowerBrook;
  • IBM in connection with the launch by Technip Energies of Reju, a company that will leverage technology IBM co‑developed in a joint venture with Under Armour and Technip Energies;
  • RELX in its acquisition of Shadow Health; 
  • Siegfried in its acquisition of Noramco, Purisys and Extractas Bioscience from SK Capital; and
  • Viatris in its global research and development collaboration with Idorsia Pharmaceuticals.

Wichtowski has also advised on intellectual property litigation matters, including securing victories for Alarm.com in patent infringement litigation brought by Vivint and securing a settlement for Biogen relating to litigation concerning its introduction of a biosimilar to Genentech’s rheumatoid arthritis drug.

Wichtowski is a registered patent attorney and a member of the New York Intellectual Property Law Association (NYIPLA).